You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Express Scripts
McKesson
Baxter
AstraZeneca

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

SOLIFENACIN SUCCINATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Solifenacin Succinate patents expire, and what generic alternatives are available?

Solifenacin Succinate is a drug marketed by Ajanta Pharma Ltd, Alembic Pharms Ltd, Alkem Labs Ltd, Amneal Pharms Co, Breckenridge, Celltrion, Cipla, Glenmark Pharms Inc, Graviti Pharms, Jiangxi Boya Seehot, MSN, Qilu, Sciegen Pharms Inc, Strides Pharma, Sunshine Lake, Teva Pharms Usa, Unichem Labs Ltd, and Watson Labs Inc. and is included in eighteen NDAs.

The generic ingredient in SOLIFENACIN SUCCINATE is solifenacin succinate. There are thirty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the solifenacin succinate profile page.

US ANDA Litigation and Generic Entry Outlook for Solifenacin Succinate

A generic version of SOLIFENACIN SUCCINATE was approved as solifenacin succinate by TEVA PHARMS USA on April 2nd, 2014.

  Start Trial

Drug patent expirations by year for SOLIFENACIN SUCCINATE
Drug Prices for SOLIFENACIN SUCCINATE

See drug prices for SOLIFENACIN SUCCINATE

Recent Clinical Trials for SOLIFENACIN SUCCINATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaPhase 4
Ono Pharmaceutical Co. LtdPhase 2
Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshPhase 4

See all SOLIFENACIN SUCCINATE clinical trials

Pharmacology for SOLIFENACIN SUCCINATE
Medical Subject Heading (MeSH) Categories for SOLIFENACIN SUCCINATE
Paragraph IV (Patent) Challenges for SOLIFENACIN SUCCINATE
Tradename Dosage Ingredient NDA Submissiondate
VESICARE TABLET;ORAL solifenacin succinate 021518 2009-04-08

US Patents and Regulatory Information for SOLIFENACIN SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 091464-002 Apr 2, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Strides Pharma SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 212214-002 Sep 26, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Unichem Labs Ltd SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 211701-001 Aug 27, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Sunshine Lake SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 213346-001 Apr 13, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Ajanta Pharma Ltd SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 205483-001 May 20, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Express Scripts
McKesson
Moodys
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.